Medtronic buys GERD (gastroesophageal reflux disease) company Endonetics
This article was originally published in Clinica
Executive Summary
Medtronic is to buy private company Endonetics, which develops technologies to diagnose and treat gastroesophageal reflux disease (GERD). Terms of the deal were not disclosed.